Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere et al. · New England Journal of Medicine · 2004 · 3.2K citations

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

Jean Bourhis, C. Domenge, L. Designé · The Lancet · 2000 · 2.5K citations

Neoadjuvant Therapy, Medicine, Locoregional Treatment +10

An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

David J. Adelstein, Yi Li, George L. Adams et al. · Journal of Clinical Oncology · 2002 · 1.7K citations

Head and neck cancer: a global perspective on epidemiology and prognosis.

R Sankaranarayanan, E. Masuyer, Rajaraman Swaminathan et al. · PubMed · 1999 · 387 citations

Neck Cancer, Epidemiology Of Cancer, Pathology +25

Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment

Dora L.�W. Kwong, Jonathan S. T. Sham, W.K. Ho et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 195 citations

Sensorineural Hearing Loss, Radiation Therapy, Medicine +10